Target intelligence / Profile preview

Long intergenic non-protein coding RNA 1140 (LINC01140)

Target
LINC01140
Molecular classification
Long non-coding RNA, Long intergenic non-coding RNA (lincRNA), Other
01

Overview

Long intergenic non-protein coding RNA 1140 (LINC01140) is a long non-coding RNA, classified as a long intergenic non-coding RNA, that plays regulatory roles in various biological processes and diseases. LINC01140 is highly expressed in several cancers, including lung, gastric, bladder, and breast cancer, where it contributes to tumor cell proliferation, migration, invasion, and immune escape, largely via "sponging" microRNAs such as miR-33a-5p, miR-33b-5p, miR-140-5p, and others. In cancer cells, LINC01140 upregulation is associated with increased PD-L1 expression and poor prognosis. Conversely, LINC01140 knockdown suppresses tumor growth, reduces metastasis, and enhances immune response by decreasing PD-L1. In fibrotic diseases, LINC01140 regulates inflammatory cytokine secretion and promotes fibrosis. Although no direct drug modulators are currently known, LINC01140 is considered a potential therapeutic target and prognostic biomarker, especially in cancer and fibrotic disease contexts

Other names
FLJ41676LINC01140
02

Biological functions

Regulation of cell proliferationRegulation of cell migrationRegulation of cell invasionInhibition of apoptosisRegulation of immune response (by modulating PD-L1)Modulation of epithelial-to-mesenchymal transition (EMT)Regulation of inflammation and fibrogenesisOther (miRNA sponge activity)
03

Disease associations

Cancer (Lung cancer, Gastric cancer, Bladder cancer, Breast cancer)InflammationPulmonary fibrosisOther
04

Safety considerations

Potential risks related to modulation of broad regulatory RNA networks (e.g., off-target effects as a therapeutic target)Unclear impact of targeting in normal physiological vs pathological contexts
05

Biomarkers

Prognostic biomarker for lung cancer (high levels associated with worse survival)Prognostic biomarker for gastric cancer and breast cancer (with disease-stage and outcome correlation)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 1140 (LINC01140).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 1140 (LINC01140).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call